✦ LIBER ✦

Percutaneous Placement of Peritoneal Port-Catheter in Patients with Malignant Ascites

✍ Scribed by Orhan Ozkan; Devrim Akinci; Rahsan Gocmen; Barbaros Cil; Mustafa Ozmen; Okan Akhan

Publisher: Springer
Year: 2007
Tongue: English
Weight: 133 KB
Volume: 30
Category: Article
ISSN: 1432-086X
DOI: 10.1007/s00270-005-0252-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peritoneal catheter for continuous drain

Peritoneal catheter for continuous drainage of ascites in advanced cancer patients

✍ Sebastiano Mercadante; Giuseppe Intravaia; Patrizia Ferrera; Patrizia Villari; F 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 90 KB

Acute cyanosis in a child after percutan

Acute cyanosis in a child after percutaneous placement of a peritoneal dialysis catheter: question

✍ Murat Anil; Alkan Bal; Ayse Berna Anil; Onder Yavascan; Orhan Deniz Kara; Nejat 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 47 KB

Acute cyanosis in a child after percutan

Acute cyanosis in a child after percutaneous placement of a peritoneal dialysis catheter: answer

✍ Murat Anil; Alkan Bal; Ayse Berna Anil; Onder Yavascan; Orhan Deniz Kara; Nejat 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 68 KB

Placement of a Port Catheter Through Col

Placement of a Port Catheter Through Collateral Veins in a Patient with Central Venous Occlusion

✍ Ulf Karl-Martin Teichgräber; Florian Streitparth; Bernhard Gebauer; Thomas Bente 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 163 KB

Tension Pneumothorax After Placement of

Tension Pneumothorax After Placement of a Tunneled Pleural Drainage Catheter in a Patient with Recurrent Malignant Pleural Effusions

✍ A.M. Wachsman; E.K. Hoffer; A.R. Forauer; A.M. Silas; J.M. Gemery 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 117 KB

Elevation of CA 125 in patients with ben

Elevation of CA 125 in patients with benign and malignant ascites

✍ Jean-François Bergmann; Jean-Michel Bidart; Martine George; Michel Beaugrand; Vi 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB 👁 2 views

The presence of CA 125, an ovarian cancer-associated antigen, was assessed in serum and ascites from patients with ovarian cancer (n = 47), hepatocellular carcinoma (n = 21), and liver cirrhosis (n = 40). Abnormal levels of serum CA 125 were observed in 49% of ovarian cancer patients, and in 89% of